“LEQEMBI®” (lecanemab) IV Maintenance Dosing for the Treatment of - The National Law Review

Retrieved on: 2025-09-29 01:57:08

Tags for this article:

Click the tags to see associated articles and topics

“LEQEMBI®” (lecanemab) IV Maintenance Dosing for the Treatment of - The National Law Review. View article details on hiswai:

Excerpt

MEDIA CONTACTS. Eisai Co., Ltd. Public Relations Department +81 (0)3-3817-5120. Eisai Europe, Ltd. (UK, Europe, Australia, New Zealand and Russia)

Article found on: natlawreview.com